Check out the new paper of our partner Carmen Labandeira "Parkinson´s disease and diabetes mellitus: common mechanisms and treatment repurposing" published in @NRRNeural 👇👇👇nrronline.org/article.asp?is…

📢📢 Check out the commentary about our article published in Clinical Science Portland Press. Jose L. Labandeira-Garcia;@CiberUb; Carmen Labandeira; Rita Valenzuela Limiñana; CiMUS; USC; Unistem Santiago Thanks to the authors Fedor Simko and Tomas Baka 👇 pubmed.ncbi.nlm.nih.gov/33881142/

📢Check out our new article, "Drugs modulating Renin-Angiotensin System in COVID-19 Treatment" published in Biomedicines MDPI by Jose L. Labandeira-Garcia and colleagues. CiMUS; USC; Unistem Santiago. It is available for reading in 👇 mdpi.com/2227-9059/10/2…

👏Congratulations to all the authors Quijano et al. Anairp Jose L. Labandeira-Garcia from Unistem Santiago CiMUS USC for your new publication via Antioxidants MDPI 📚Read via mdpi.com/2076-3921/11/2…… #antioxidants #inflammasome #neurodegeneration

📢📢🔬More about Renin Angiotensin System Autoantibodies in #Covid_19. Find out by reading our latest paper published in Frontiers - Medicine. Carmen Labandeira, Jose L. Labandeira-Garcia, Unistem Santiago, Juan Suárez Quintanilla, CiMUS, USC.👇👇👇 frontiersin.org/articles/10.33…

AT1 autoantibodies also increased levels of neuroinflammation markers, which was inhibited by the AT1 antagonist candesartan; The autoantibodies were also found in PD cerebrospinal fluid; Further support for repurposing angiotensin type-1 receptor blockers for #Parkinsons?

Jose L. Labandeira-Garcia, from @CIBERNED, CiMUS and USC publishes in Movement Disorders Journal the host topic "Nigral Neurons Degenerating in Parkinson's Disease Express the Angiotensin Receptor Type 1 Gene". Find out by reading 👇👇 …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md…

Un trabajo colaborativo del Unistem Santiago (CiMUS, USC) y del @Com_CHUO estudia la posible utilidad de fármacos contra el #síndromemetabólico o la #diabetes en el tratamiento del #Parkinson. usc.es/cimus/es/notic…

🔬Unha investigación do CiMUS avalía o uso de fármacos antihipertensivos no tratamento da enfermidade de #Parkinson As achegas son froito da tese de doutoramento que a neuróloga Carmen Labandeira desenvolveu na USC 🗞️ usc.gal/gl/xornal/nova…

Enhorabuena a nuestra compañera Carmen Labandeira de Unistem Santiago (en CiMUS; USC ) y @Com_CHUO por su trabajo. Hoy La Voz de Galicia se hace eco de sus hallazgos y permite acercar a la sociedad el fruto de su arduo trabajo. lavozdegalicia.es/noticia/socied…

💊💊Vías gallegas contra el #Parkinson. Faro de Vigo nos acerca a la investigación de Carmen Labandeira (CiMUS en USC y @Com_CHUO) que profundiza en el estudio de fármacos contra #sindromemetabólico y #diabetes en el Parkinson.👇 farodevigo.es/sociedad/2022/…

🩺🔬El trabajo de nuestra investigadora clínica Carmen Labandeira de CiMUS (USC ) y @Com_CHUO sobre reposición de fármacos antihipertensivos y antidiabéticos para el tratamiento del #Parkinson en La Región laregion.es/articulo/ouren…

Investigan la eficacia de fármacos contra la diabetes en el párkinson lavanguardia.com/vida/20220708/…

👩‍🎓Felicidades a Carmen Labandeira, nuestra recién estrenada doctora de Unistem Santiago (en CiMUS de USC) y @Com_CHUO por su brillante defensa de la tesis: "Autoinmunidad y SRA en la Enfermedad de Parkinson" 📎bit.ly/3F0bZHr

📢📢🔬 The latest results of Jose L. Labandeira-Garcia Lab (Unistem Santiago , CiMUS , USC ) show that Angiotensin receptor autoantibodies are a link between MetS and #Parkinson’s disease. Check out in BrainBehavImm 👇 sciencedirect.com/science/articl…

Follow up research from Carmen Labandeira Jose L. Labandeira-Garcia & colleagues showing angiotensin receptor type 1 autoantibodies increase nigral proinflammatory activity & neurodegeneration in preclinical models of #Parkinsons sciencedirect.com/science/articl…

📢 🔬The latest article from Jose L. Labandeira-Garcia (CiMUS USC TERAV @ciberned) "Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia" is just out in Antioxidants MDPI ‼️👇 mdpi.com/2076-3921/12/7…